Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors.

Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P, Vogelstein B.

Science. 1992 Apr 3;256(5053):102-5.

PMID:
1566048
2.

Detecting colorectal cancer in stool with the use of multiple genetic targets.

Dong SM, Traverso G, Johnson C, Geng L, Favis R, Boynton K, Hibi K, Goodman SN, D'Allessio M, Paty P, Hamilton SR, Sidransky D, Barany F, Levin B, Shuber A, Kinzler KW, Vogelstein B, Jen J.

J Natl Cancer Inst. 2001 Jun 6;93(11):858-65.

PMID:
11390535
3.

Frequent detection of K-ras mutation in stool samples of colorectal carcinoma patients after improved DNA extraction: comparison with tissue samples.

Ito Y, Kobayashi S, Taniguchi T, Kainuma O, Hara T, Ochiai T.

Int J Oncol. 2002 Jun;20(6):1263-8.

PMID:
12012008
4.

Prognostic significance of K-ras mutations in colorectal carcinoma.

Benhattar J, Losi L, Chaubert P, Givel JC, Costa J.

Gastroenterology. 1993 Apr;104(4):1044-8.

PMID:
8462792
5.

Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumors by mutant-allele-specific amplification (MASA).

Hasegawa Y, Takeda S, Ichii S, Koizumi K, Maruyama M, Fujii A, Ohta H, Nakajima T, Okuda M, Baba S, et al.

Oncogene. 1995 Apr 6;10(7):1441-5.

PMID:
7731696
6.

[Determination of the activated proto-oncogene (Ki-ras) in feces. A new laboratory analysis for early diagnosis of colorectal cancer].

Koornstra JJ, Røkke O, Halvorsen JF, Haug K, Ogreid D.

Tidsskr Nor Laegeforen. 1995 Oct 30;115(26):3266-70. Review. Norwegian.

PMID:
7482456
7.

K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.

Wilentz RE, Chung CH, Sturm PD, Musler A, Sohn TA, Offerhaus GJ, Yeo CJ, Hruban RH, Slebos RJ.

Cancer. 1998 Jan 1;82(1):96-103.

PMID:
9428484
8.

Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors.

Kusaka T, Fukui H, Sano Y, Ueda Y, Chiba T, Fujimori T.

J Gastroenterol Hepatol. 2000 Oct;15(10):1151-7.

PMID:
11106095
9.

[Detection of K-ras point mutations in the stool of patients with colorectal tumors].

Kohata Y.

Nihon Shokakibyo Gakkai Zasshi. 1996 Jun;93(6):391-7. Japanese.

PMID:
8752756
10.

Ras proto-oncogene activation in liver and lung tumors from B6C3F1 mice exposed chronically to methylene chloride.

Devereux TR, Foley JF, Maronpot RR, Kari F, Anderson MW.

Carcinogenesis. 1993 May;14(5):795-801.

PMID:
8504471
11.

Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool.

Villa E, Dugani A, Rebecchi AM, Vignoli A, Grottola A, Buttafoco P, Losi L, Perini M, Trande P, Merighi A, Lerose R, Manenti F.

Gastroenterology. 1996 May;110(5):1346-53.

PMID:
8613038
12.

Noninvasive detection through REMS-PCR technique of K-ras mutations in stool DNA of patients with colorectal cancer.

Mixich F, Ioana M, Voinea F, Săftoiu A, Ciurea T.

J Gastrointestin Liver Dis. 2007 Mar;16(1):5-10.

13.

APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.

Hsieh JS, Lin SR, Chang MY, Chen FM, Lu CY, Huang TJ, Huang YS, Huang CJ, Wang JY.

Am Surg. 2005 Apr;71(4):336-43.

PMID:
15943410
14.

K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer.

Anker P, Lefort F, Vasioukhin V, Lyautey J, Lederrey C, Chen XQ, Stroun M, Mulcahy HE, Farthing MJ.

Gastroenterology. 1997 Apr;112(4):1114-20.

PMID:
9097993
15.

Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel.

Ahlquist DA, Skoletsky JE, Boynton KA, Harrington JJ, Mahoney DW, Pierceall WE, Thibodeau SN, Shuber AP.

Gastroenterology. 2000 Nov;119(5):1219-27.

PMID:
11054379
16.

Fecal multiple molecular tests to detect colorectal cancer in stool.

Calistri D, Rengucci C, Bocchini R, Saragoni L, Zoli W, Amadori D.

Clin Gastroenterol Hepatol. 2003 Sep;1(5):377-83.

PMID:
15017656
17.

Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients.

Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S, Hedge P.

Science. 1991 Aug 9;253(5020):665-9.

PMID:
1651563
18.

Synchronous colon carcinomas: molecular-genetic evidence for multicentricity.

Koness RJ, King TC, Schechter S, McLean SF, Lodowsky C, Wanebo HJ.

Ann Surg Oncol. 1996 Mar;3(2):136-43.

PMID:
8646513
19.

Detection of the mutated K-Ras biomarker in colorectal carcinoma.

Doolittle BR, Emanuel J, Tuttle C, Costa J.

Exp Mol Pathol. 2001 Jun;70(3):289-301.

PMID:
11418008
20.

Detection of K-ras mutation in colonic effluent samples from patients without evidence of colorectal carcinoma.

Tobi M, Luo FC, Ronai Z.

J Natl Cancer Inst. 1994 Jul 6;86(13):1007-10.

PMID:
8007010

Supplemental Content

Support Center